Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

24. Januar 2019 08:15 ET | Quelle: Hofseth Biocare ASA

Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE, PRIMARY INSIDER IN HOFSETH BIOCARE ASA

Hofseth AS, a 100 % owned company of Hofseth International AS (partly, indirectly owned by CEO Roger Hofseth and Chairman of the Board Ola Holen), has today received 185,714 shares in Hofseth BioCare...
10. Dezember 2018 05:52 ET | Quelle: Hofseth Biocare ASA

Hofseth BioCare ASA: NEW STUDY SHOWS CALGO® IS SUPERIOR TO TRADITIONAL CALCIUM SOURCES ON OSTEOBLAST AND CALCIUM DEPOSITION

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hofseth BioCare ASA (HBC) produces CalGo®,...
02. November 2018 03:02 ET | Quelle: Hofseth Biocare ASA

Hofseth Biocare ASA: HBC Third Quarter 2018 Financial Report

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hofseth BioCare had operating revenues of NOK...
26. September 2018 05:31 ET | Quelle: Hofseth Biocare ASA

Hofseth Biocare ASA: REGISTRATION OF SHARE CAPITAL INCREASE

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Reference is made to the stock exchange notice...
11. September 2018 08:36 ET | Quelle: Hofseth Biocare ASA

Hofseth Biocare ASA: Result of the subsequent offering

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Reference is made to the stock exchange...
10. September 2018 02:15 ET | Quelle: Hofseth Biocare ASA

Hofseth Biocare ASA: LAST DAY OF SUBSCRIPTION PERIOD

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Reference is made to the stock exchange notice...
06. September 2018 03:05 ET | Quelle: Hofseth Biocare ASA

Hofseth Biocare ASA: New study and US provisional patent filed on regulation of oxidative protective genes in human cells with ProGo for treatment of IBD, such as ulcerative colitis and Crohn's

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} An invitro study on the regulation of...
27. August 2018 10:17 ET | Quelle: Hofseth Biocare ASA

Hofseth Biocare ASA: HBC Second Quarter 2018 Financial Report

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hofseth BioCare ASA had operating revenues of...
24. August 2018 01:50 ET | Quelle: Hofseth Biocare ASA

Hofseth Biocare ASA: PUBLICATION OF PROSPECTUS - FURTHER INFORMATION ABOUT THE SUBSEQUENT OFFERING

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Reference is made to the stock exchange...
02. August 2018 10:27 ET | Quelle: Hofseth Biocare ASA

Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Reference is made to the Private Placement...

Vorherige Seite

Nächste Seite